Literature DB >> 20427538

Regulation of hepatitis C virus translation and infectious virus production by the microRNA miR-122.

Rohit K Jangra1, Minkyung Yi, Stanley M Lemon.   

Abstract

miR-122 is a liver-specific microRNA that positively regulates hepatitis C virus (HCV) RNA abundance and is essential for production of infectious HCV. Using a genetic approach, we show that its ability to enhance yields of infectious virus is dependent upon two miR-122-binding sites near the 5' end of the HCV genome, S1 and S2. Viral RNA with base substitutions in both S1 and S2 failed to produce infectious virus in transfected cells, while virus production was rescued to near-wild-type levels in cells supplemented with a complementary miR-122 mutant. A comparison of mutants with substitutions in only one site revealed S1 to be dominant, as an S2 but not S1 mutant produced high virus yields in cells supplemented with wild-type miR-122. Translation of HCV RNA was reduced over 50% by mutations in either S1 or S2 and was partially rescued by transfection of the complementary miR-122 mutant. Unlike the case for virus replication, however, both sites function equally in regulating translation. We conclude that miR-122 promotes replication by binding directly to both sites in the genomic RNA and, at least in part, by stimulating internal ribosome entry site (IRES)-mediated translation. However, a comparison of the replication capacities of the double-binding-site mutant and an IRES mutant with a quantitatively equivalent defect in translation suggests that the decrement in translation associated with loss of miR-122 binding is insufficient to explain the profound defect in virus production by the double mutant. miR-122 is thus likely to act at an additional step in the virus life cycle.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20427538      PMCID: PMC2903297          DOI: 10.1128/JVI.00417-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5' UTR as in the 3' UTR.

Authors:  J Robin Lytle; Therese A Yario; Joan A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-29       Impact factor: 11.205

2.  miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1.

Authors:  Jinhong Chang; Emmanuelle Nicolas; Debora Marks; Chris Sander; Anthony Lerro; Marie Annick Buendia; Chunxiao Xu; William S Mason; Thomas Moloshok; Roque Bort; Kenneth S Zaret; John M Taylor
Journal:  RNA Biol       Date:  2004-07-01       Impact factor: 4.652

3.  AU-rich-element-mediated upregulation of translation by FXR1 and Argonaute 2.

Authors:  Shobha Vasudevan; Joan A Steitz
Journal:  Cell       Date:  2007-03-23       Impact factor: 41.582

4.  Compensatory mutations in E1, p7, NS2, and NS3 enhance yields of cell culture-infectious intergenotypic chimeric hepatitis C virus.

Authors:  MinKyung Yi; Yinghong Ma; Jeremy Yates; Stanley M Lemon
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

5.  Hepatitis C virus p7 and NS2 proteins are essential for production of infectious virus.

Authors:  Christopher T Jones; Catherine L Murray; Dawnnica K Eastman; Jodie Tassello; Charles M Rice
Journal:  J Virol       Date:  2007-05-30       Impact factor: 5.103

6.  Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells.

Authors:  MinKyung Yi; Rodrigo A Villanueva; David L Thomas; Takaji Wakita; Stanley M Lemon
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-06       Impact factor: 11.205

7.  Switching from repression to activation: microRNAs can up-regulate translation.

Authors:  Shobha Vasudevan; Yingchun Tong; Joan A Steitz
Journal:  Science       Date:  2007-11-29       Impact factor: 47.728

8.  Cellular cofactors affecting hepatitis C virus infection and replication.

Authors:  Glenn Randall; Maryline Panis; Jacob D Cooper; Timothy L Tellinghuisen; Karen E Sukhodolets; Sebastien Pfeffer; Markus Landthaler; Pablo Landgraf; Sherry Kan; Brett D Lindenbach; Minchen Chien; David B Weir; James J Russo; Jingyue Ju; Michael J Brownstein; Robert Sheridan; Chris Sander; Mihaela Zavolan; Thomas Tuschl; Charles M Rice
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-06       Impact factor: 11.205

9.  Association between hepatitis C virus and very-low-density lipoprotein (VLDL)/LDL analyzed in iodixanol density gradients.

Authors:  Søren U Nielsen; Margaret F Bassendine; Alastair D Burt; Caroline Martin; Wanna Pumeechockchai; Geoffrey L Toms
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

Review 10.  Reliance of host cholesterol metabolic pathways for the life cycle of hepatitis C virus.

Authors:  Jin Ye
Journal:  PLoS Pathog       Date:  2007-08-31       Impact factor: 6.823

View more
  143 in total

Review 1.  MicroRNAs and liver disease.

Authors:  Thomas A Kerr; Kevin M Korenblat; Nicholas O Davidson
Journal:  Transl Res       Date:  2011-02-02       Impact factor: 7.012

2.  Expression of microRNA miR-122 facilitates an efficient replication in nonhepatic cells upon infection with hepatitis C virus.

Authors:  Takasuke Fukuhara; Hiroto Kambara; Mai Shiokawa; Chikako Ono; Hiroshi Katoh; Eiji Morita; Daisuke Okuzaki; Yoshihiko Maehara; Kazuhiko Koike; Yoshiharu Matsuura
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

3.  Base pairing between hepatitis C virus RNA and microRNA 122 3' of its seed sequence is essential for genome stabilization and production of infectious virus.

Authors:  Tetsuro Shimakami; Daisuke Yamane; Christoph Welsch; Lucinda Hensley; Rohit K Jangra; Stanley M Lemon
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

4.  Hepatitis C virus infection stimulates transforming growth factor-β1 expression through up-regulating miR-192.

Authors:  Ji Hyun Kim; Chang Ho Lee; Seong-Wook Lee
Journal:  J Microbiol       Date:  2016-06-28       Impact factor: 3.422

5.  Characterization of nonprimate hepacivirus and construction of a functional molecular clone.

Authors:  Troels K H Scheel; Amit Kapoor; Eiko Nishiuchi; Kenny V Brock; Yingpu Yu; Linda Andrus; Meigang Gu; Randall W Renshaw; Edward J Dubovi; Sean P McDonough; Gerlinde R Van de Walle; W Ian Lipkin; Thomas J Divers; Bud C Tennant; Charles M Rice
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

6.  End game: getting the most out of microRNAs.

Authors:  Shihyun You; Catherine L Murray; Joseph M Luna; Charles M Rice
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-09       Impact factor: 11.205

7.  The 3 prime paradigm of the miR-200 family and other microRNAs.

Authors:  Graham J Brock; Sterghios Moschos; Simon D Spivack; Gregory J Hurteau
Journal:  Epigenetics       Date:  2011-03-01       Impact factor: 4.528

8.  Positive Regulation of Hepatitis E Virus Replication by MicroRNA-122.

Authors:  Bangari Haldipur; Prudhvi Lal Bhukya; Vidya Arankalle; Kavita Lole
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

9.  Competing and noncompeting activities of miR-122 and the 5' exonuclease Xrn1 in regulation of hepatitis C virus replication.

Authors:  You Li; Takahiro Masaki; Daisuke Yamane; David R McGivern; Stanley M Lemon
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-17       Impact factor: 11.205

10.  Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis C.

Authors:  Tung-Hung Su; Chen-Hua Liu; Chun-Jen Liu; Chi-Ling Chen; Te-Tien Ting; Tai-Chung Tseng; Pei-Jer Chen; Jia-Horng Kao; Ding-Shinn Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.